Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Galectin-8 is a potential therapeutic target for cancer, inflammation, and bone disorders.
• Understanding galectin-8 function requires specific molecular probes.
• Existing galectin-8 ligands need improved affinity and selectivity.

Purpose of the Study:

• To enhance the affinity and target selectivity of a known galectin-8 ligand.
• To develop novel molecular probes for galectin-8 research.
• To investigate galectin-8's role in disease through advanced probes.

Main Methods:

• Chemical modification of a previously identified galectin-8 ligand (3-O-[1-carboxyethyl]-β-d-galactopyranoside).
• Introduction of modifications at positions 1 and 3 of the galactose moiety.
• Affinity measurement using fluorescence polarization assays.

Main Results:

• The most potent modified compound exhibited a dissociation constant (K_D) of 12 μM.
• The developed ligands demonstrated reasonable selectivity against other galectins.
• Successful optimization of ligand properties for galectin-8 targeting.

Conclusions:

• The modified galectin-8 ligand represents a promising lead compound.
• These novel ligands can serve as effective molecular probes for galectin-8.
• Further studies in cell-based and in vivo models are warranted to explore galectin-8's functions.